CLINICAL_TRIALS trial_result · 2026-08-10

Clinical Trial Results: Efficacy and Safety of MK-6194 in Adult Participants With Systemic Lupus Erythematosus (MK-6194-006) [Phase 2]

Phase 2 trial results for MK-6194 in adults with systemic lupus erythematosus were terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: TERMINATED | Results posted: 2026-08-10